Photo

Photo detail

Eric Ostertag
Poseida CEO

Stories this photo appears in:

Poseida Therapeutics Raises $142M in Series C Round

Poseida Therapeutics raised $142 million in a Series C round to advance therapies that alter immune cells to kill cancer.

Tease photo